Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches.
Khosla D, Misra S, Chu PL, Guan P, Nada R, Gupta R, Kaewnarin K, Ko TK, Heng HL, Srinivasalu VK, Kapoor R, Singh D, Klanrit P, Sampattavanich S, Tan J, Kongpetch S, Jusakul A, Teh BT, Chan JY, Hong JH. Khosla D, et al. Among authors: klanrit p. Cancers (Basel). 2024 Feb 16;16(4):801. doi: 10.3390/cancers16040801. Cancers (Basel). 2024. PMID: 38398194 Free PMC article. Review.
Mismatch Repair Deficiency Is a Prognostic Factor Predicting Good Survival of Opisthorchis viverrini-Associated Cholangiocarcinoma at Early Cancer Stage.
Khuntikeo N, Padthaisong S, Loilome W, Klanrit P, Ratchatapusit S, Techasen A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Chindaprasirt J, Sa-Ngiamwibool P, Aphivatanasiri C, Intarawichian P, Koonmee S, Prajumwongs P, Titapun A. Khuntikeo N, et al. Among authors: klanrit p. Cancers (Basel). 2023 Oct 2;15(19):4831. doi: 10.3390/cancers15194831. Cancers (Basel). 2023. PMID: 37835526 Free PMC article.
Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies.
Hong JH, Yong CH, Heng HL, Chan JY, Lau MC, Chen J, Lee JY, Lim AH, Li Z, Guan P, Chu PL, Boot A, Ng SR, Yao X, Wee FYT, Lim JCT, Liu W, Wang P, Xiao R, Zeng X, Sun Y, Koh J, Kwek XY, Ng CCY, Klanrit P, Zhang Y, Lai J, Tai DWM, Pairojkul C, Dima S, Popescu I, Hsieh SY, Yu MC, Yeong J, Kongpetch S, Jusakul A, Loilome W, Tan P, Tan J, Teh BT. Hong JH, et al. Among authors: klanrit p. Gut. 2024 May 10;73(6):966-984. doi: 10.1136/gutjnl-2023-330483. Gut. 2024. PMID: 38050079
In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues.
Suksawat M, Klanrit P, Phetcharaburanin J, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Sa-Ngiamwibool P, Techasen A, Loilome W. Suksawat M, et al. Among authors: klanrit p. PLoS One. 2019 Sep 10;14(9):e0222140. doi: 10.1371/journal.pone.0222140. eCollection 2019. PLoS One. 2019. PMID: 31504065 Free PMC article.
Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma.
Padthaisong S, Phetcharaburanin J, Klanrit P, Li JV, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Wangwiwatsin A, Mahalapbutr P, Loilome W. Padthaisong S, et al. Among authors: klanrit p. Cancer Metab. 2021 Aug 4;9(1):30. doi: 10.1186/s40170-021-00266-5. Cancer Metab. 2021. PMID: 34348794 Free PMC article.
In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines.
Dokduang H, Jamnongkarn W, Promraksa B, Suksawat M, Padthaisong S, Thanee M, Phetcharaburanin J, Namwat N, Sangkhamanon S, Titapun A, Khuntikeo N, Klanrit P, Loilome W. Dokduang H, et al. Among authors: klanrit p. Drug Des Devel Ther. 2020 Jun 11;14:2319-2334. doi: 10.2147/DDDT.S250061. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32606601 Free PMC article.
Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression.
Tomacha J, Dokduang H, Padthaisong S, Namwat N, Klanrit P, Phetcharaburanin J, Wangwiwatsin A, Khampitak T, Koonmee S, Titapun A, Jarearnrat A, Khuntikeo N, Loilome W. Tomacha J, et al. Among authors: klanrit p. Front Pharmacol. 2021 Aug 4;12:696961. doi: 10.3389/fphar.2021.696961. eCollection 2021. Front Pharmacol. 2021. PMID: 34421595 Free PMC article.
Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.
Suksawat M, Phetcharaburanin J, Klanrit P, Namwat N, Khuntikeo N, Titapun A, Jarearnrat A, Vilayhong V, Sa-Ngiamwibool P, Techasen A, Wangwiwatsin A, Mahalapbutr P, Li JV, Loilome W. Suksawat M, et al. Among authors: klanrit p. Front Public Health. 2022 Feb 10;10:766023. doi: 10.3389/fpubh.2022.766023. eCollection 2022. Front Public Health. 2022. PMID: 35223723 Free PMC article.
74 results